Trial intelligence / Profile preview

Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery

NCT02796820Phase 3Unknown

Sponsor
The Sixth Affiliated Hospital of Sun Yat-Sen University
Start
Jun 2016
Primary completion
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in colorectal cancer (CRC) comparing Huaier Granule with Regular follow-up observation (2 arms). Primary endpoint: Disease-free survival at 1 year. Status: unknown.

02

Drugs

huaier granule
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02796820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02796820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call